University of Pennsylvania

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).

1,423 total trials 199 currently recruiting 982 completed early-phase tilt top decile by trial count

University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.

University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.

Top-decile sponsor footprint

University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,423 total, page 20 of 29

TERMINATED Phase 2

Sorafenib for Hepatopulmonary Syndrome

NCT02021929

TERMINATED NA

Usability Testing of Affordable Haptic Robots for Stroke Therapy

NCT02772809

COMPLETED Phase 2

Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia

NCT02030847

COMPLETED Phase 2

Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas

NCT02030834

COMPLETED NA

Way to Be Active III (Framing Incentives)

NCT02030119

COMPLETED NA

Prevention of Preterm Birth With a Pessary in Singleton Gestations

NCT02056652

COMPLETED NA

Using a Motivational Interviewing (MI) Informed Text Messaging Program to Lower Blood Sugar in Diabetic Patients.

NCT02012478

COMPLETED Phase 3

The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach

NCT01940094

COMPLETED NA

Prevention of Preterm Birth With a Pessary in Twin Gestations

NCT02056639

COMPLETED

Mobile Service Robot for Task-Oriented Stroke Therapy: User Evaluations

NCT02779517

COMPLETED NA

Way to Be Active 2 (Lotteries)

NCT02005276

COMPLETED NA

PATH For Triples Study: Medication and Lifestyle Adherence for HIV+ Patients

NCT02185144

COMPLETED Phase 1

Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension

NCT02080533

COMPLETED NA

Postpartum Weight Retention

NCT02867631

COMPLETED NA

Social Forces to Improve Statin Adherence (Study A)

NCT02018809

COMPLETED NA

Way to Be Active IV (Framing vs Incentives)

NCT02030080

COMPLETED NA

A Randomized Trial of Patient Financial Incentives to Reduce CVD Risk

NCT02035826

COMPLETED NA

Way to Be Active V (Framing vs. Forgiveness)

NCT02030132

COMPLETED NA

Social Forces to Improve Statin Adherence (Study B)

NCT02148523

COMPLETED NA

Default Options in Advance Directives

NCT02017548

COMPLETED Phase 3

Comparative Effectiveness of Pregnancy Failure Management Regimens

NCT02012491

TERMINATED NA

A Cluster-randomized, Pragmatic Trial of Hemodialysis Session Duration

NCT02019225

COMPLETED NA

A Patient Advocate to Improve Real-world Asthma Management for Inner City Adults

NCT01972308

COMPLETED NA

Take Charge of Your Diabetes

NCT01977495

COMPLETED Phase 2

Baclofen Effects on Marijuana Dependence

NCT02011516

COMPLETED Phase 1

Indocyanine Green for Solid Tumors

NCT02280954

COMPLETED

Thromboelastography-derived Functional Fibrinogen Levels

NCT01992757

COMPLETED Phase 1

EC17 for Intraoperative Imaging for Parathyroidectomy

NCT01996072

COMPLETED NA

Temporary Biventricular Pacing

NCT01987531

COMPLETED NA

Food and Crohn's Exacerbation Study (FACES)

NCT01926730

COMPLETED Phase 1

EC17 for Intraoperative Imaging in Occult Ovarian Cancer

NCT02000778

COMPLETED NA

Using Patient Feedback to Improve Communication Regarding Glycemic Control to Patients With Diabetes

NCT01886170

COMPLETED

Metabolomics of Insomnia-Related Hyperarousal

NCT01957111

COMPLETED

Motherhood and Microbiome

NCT02030106

COMPLETED Phase 2

Bolus of Saline in Stroke

NCT01971463

COMPLETED NA

A Trial To Assess Risk of Delirium in Older Adults Undergoing Hip Fracture Surgery With Spinal or General Anesthesia

NCT02190903

COMPLETED NA

The Efficacy of 90-Minute Versus 60-Minute Sessions of Prolonged Exposure for PTSD

NCT02720497

COMPLETED NA

Financial Incentives for Maintenance of Weight Loss

NCT01900392

COMPLETED NA

An Electronic Alert System for In-Hospital Acute Kidney Injury

NCT01862419

COMPLETED NA

The Effect of Synching Prescription Refills on Adherence

NCT01934608

COMPLETED NA

PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk

NCT01879189

COMPLETED NA

Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure

NCT01911585

COMPLETED NA

Participatory Design of Patient-centered Depression and Diabetes Care

NCT02178176

COMPLETED NA

Young Adults' Responses to Anti-smoking Messages

NCT01954407

COMPLETED NA

Nicotine Metabolism and Low Nicotine Cigarettes

NCT01898507

COMPLETED

Understanding Disparities in Healthcare and Primary Care Provider Quality

NCT02626910

COMPLETED Phase 2

11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension

NCT01917136

COMPLETED

Difficult Intravenous Access Perception: Difficult IV Access - Assessment of Patient Understanding

NCT01929304

TERMINATED NA

Second Study to Assess Different Ablation Strategies in Achieving Long-Term Arrhythmia Control in Patients With Persistent or Long Standing Persistent Atrial Fibrillation

NCT02019238

COMPLETED Phase 2

Ghrelin Plus Strength Training in Frail Elderly Study

NCT01898611

← Previous Page 20 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 182
Phase 2 157
Phase 3 43
Phase 4 87

What is open in the University of Pennsylvania pipeline

199 recruiting of 1,423 indexed (14% open); 982 completed (69%).

Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).

Top condition: Obesity (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.